FXS6837 for the Treatment of IgAN Patients

NCT07502638 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

IgAN

Interventions

DRUG: FXS6837 Dose 1
DRUG: FXS6837 Dose 2
DRUG: Placebo Capsule

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.